D2切除淋巴结阳性胃癌辅助同步放化疗的必要性
本研究基于机构登记数据,纳入2004年12月至2013年1月间接受根治性D2及R0切除、病理证实淋巴结转移且无远处转移的胃癌患者,比较辅助同步放化疗(CCRT)与单纯化疗(CA)的结局。共1633例(CCRT组909例,CA组724例),中位随访65.4个月。单变量分析中两组无复发生存(RFS)无显著差异(p=0.92),多变量校正后CCRT组RFS显著更高(p=0.03,HR 0.801,95%CI 0.658-0.975)。
要点
- D2切除淋巴结阳性胃癌中,校正后CCRT组RFS显著高于CA组(p=0.03,HR 0.801,95%CI 0.658-0.975)。
- 单变量分析中CCRT与CA组RFS无显著差异(p=0.92)。
- 两组在年龄、Lauren分型、淋巴结转移数目及pN分期上存在显著差异(p<0.0001、p=0.02、p<0.0001、p<0.0001)。
核心结论
- 在D2切除淋巴结转移性胃癌患者中,校正后CCRT组RFS显著高于CA组。
研究设计与样本
- 基于机构登记数据的分析,纳入2004年12月至2013年1月接受根治性D2及R0切除、术后辅助CCRT或CA、病理证实淋巴结转移且无远处转移的胃癌患者。
- 共纳入1633例患者,其中辅助CCRT组909例,CA组724例,中位随访65.4个月(范围3.9-141.7个月)。
主要发现
- CCRT组与CA组在年龄(p<0.0001)、Lauren分型(p=0.02)、淋巴结转移数目(p<0.0001)及pN分期(p<0.0001)上差异显著。
- 随访期间总体复发419例(25.7%),CCRT组236例(26.0%),CA组183例(25.3%)。
- 单变量分析中CCRT组与CA组RFS无显著差异(p=0.92)。
- 多变量Cox回归分析中pT/pN分期及神经侵犯有统计学意义,校正后CCRT组RFS显著更高(p=0.03,HR 0.801,95%CI 0.658-0.975)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: To investigate the role of adjuvant concurrent chemo-radiotherapy (CCRT) by analyzing the outcomes of adjuvant CCRT versus chemotherapy alone (CA) in patients with D2-resected gastric cancer with lymph node (LN) metastasis. MATERIALS AND METHODS: Patients with gastric cancer from the institutional registry who underwent curative D2 and R0 resection from December 2004 to January 2013 followed by adjuvant CCRT or CA and demonstrated pathologically confirmed LN metastasis without distant metastasis were included in the study. RESULTS: A total of 1633 patients were included (909 patients in the adjuvant CCRT group and 724 patients in the CA group), and median follow-up was 65.4 months (range, 3.9-141.7 months). There was a significant difference in age (p < 0.0001), Lauren's classification (p = 0.02), number of LN metastases (p < 0.0001), and pN stage (p < 0.0001) between the CCRT and CA groups. During follow-up, recurrence was detected in 419 (25.7%) of patients overall, 236 (26.0%) in the CCRT group, and 183 (25.3%) in the CA group. Recurrence-free survival (RFS) was not significantly different between the CCRT and CA groups in univariable analysis (p = 0.92). After adjustment, pT/pN stage and perineural invasion showed statistical significance in multivariable Cox regression analysis; however, RFS was significantly higher in the CCRT group (p = 0.03, hazard ratio 0.801, 95% confidence interval 0.658-0.975). CONCLUSIONS: The adjusted RFS was significantly higher in the CCRT group than the CA group in patients with D2 resected LN metastatic gastric cancer.
引用
- Yu JI, Lim DH, Lee J, et al. Necessity of adjuvant concurrent chemo-radiotherapy in D2-resected LN-positive gastric cancer. Radiother Oncol. 2018. PMID: 30037498. doi:10.1016/j.radonc.2018.07.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。